Company Filing History:
5 out of 5 
2 out of 2 Years Active: 1986-2004
Title: The Innovations of Giorgio G Zagnoli
Introduction
Giorgio G Zagnoli is a notable inventor based in Como, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes and formulations. With a total of 7 patents to his name, Zagnoli's work has had a considerable impact on the industry.
Latest Patents
One of Zagnoli's latest patents is a process for the preparation of granular and porous sucralfate dry gel. This invention involves creating a sucralfate gel in a dry state, which is in porous granular form. The particle-size distribution ranges between 100 and 1000 µm, with an apparent density of the powder bed between 0.7 and 0.9 g/ml. The settling index is between 5 and 15%, and the residual humidity is maintained between 5 and 15%. The preparation process includes a treatment with microwaves of a diluted solution of powdered sucralfate gel, with a sucralfate titer of between 20 and 70 wt. %. This solid product is advantageous for preparing solid pharmaceutical compositions, either as a single active principle or as a coating for compositions containing substances that may cause lesions to the gastric mucosa.
Career Highlights
Throughout his career, Giorgio G Zagnoli has worked with several prominent companies in the pharmaceutical sector. Notably, he has been associated with Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.a. and Lisapharma Spa. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Zagnoli has collaborated with notable professionals in his field, including Paolo Colombo and Ubaldo Conte. These collaborations have likely enriched his work and led to further advancements in his inventions.
Conclusion
Giorgio G Zagnoli is a distinguished inventor whose contributions to pharmaceutical innovations are noteworthy. His patents, particularly in the area of sucralfate formulations, demonstrate his commitment to improving healthcare solutions. His career and collaborations reflect a dedication to advancing the field of pharmaceuticals.